Skip to main content
Clinical Trials/IRCT2015082323732N1
IRCT2015082323732N1CompletedPhase 2

Effect of Maa-al-shaeer (An Iranian Traditional Medicine product) on treatment of allergic rhinitis in comparison with fexofenadine

Vice chancellor for research, Shahid Beheshti University of Medical Sciences0 sites80 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
7 years to 65 years (—)
Sex
All

Inclusion Criteria

  • •All patients 7 years to 65 years old that according to the ARIA guideline and diagnosis of a pulmonologist have allergic rhinitis a
  • •Exclusion criteria: Diffused Nasal Polyps; Pregnancy; history of allergy to Fexofenadine or barley; Celiac disease; systemic inflammatory diseases; using antihistamines during the last week before the beginning of the study; using Corticosteroids during the last 2 weeks before the beginning of the study; Using other antihistamine drugs during the study; using corticosteroid drugs during the study; Lack of consent from the patient to stay in the study for any reason; drug intolerance or allergic reactions

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research, Shahid Beheshti University of Medical Sciences

Similar Trials

Effect of Maa-al-shaeer (An Iranian... | Clinical Trial